Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of SP for IPTp in Uganda
NCT01184911Phase 4Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Oct 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sulfadoxine + pyrimethamine in Plasmodium falciparum malaria, sponsored by University of California, San Francisco. Primary endpoint: Parasite clearance at 42 days. Planned start Oct 2010; status: withdrawn.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01184911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01184911.